Nan Fung Trinity’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-217,014
| Closed | -$18M | – | 21 |
|
|
2022
Q2 | $18M | Sell |
217,014
-63,400
| -23% | -$5.25M | 5% | 9 |
|
|
2022
Q1 | $21.6M | Buy |
280,414
+24,600
| +10% | +$1.9M | 4.13% | 10 |
|
|
2021
Q4 | $22.6M | Hold |
255,814
| – | – | 4.91% | 10 |
|
|
2021
Q3 | $19.8M | Hold |
255,814
| – | – | 4.7% | 8 |
|
|
2021
Q2 | $21.3M | Buy |
255,814
+25,900
| +11% | +$2.16M | 4.47% | 10 |
|
|
2021
Q1 | $17.4M | Buy |
229,914
+68,500
| +42% | +$5.17M | 3.82% | 10 |
|
|
2020
Q4 | $14.2M | Buy |
161,414
+25,500
| +19% | +$2.24M | 2.51% | 13 |
|
|
2020
Q3 | $10.3M | Buy |
135,914
+58,150
| +75% | +$4.42M | 2.09% | 13 |
|
|
2020
Q2 | $9.59M | Hold |
77,764
| – | – | 2.13% | 15 |
|
|
2020
Q1 | $6.57M | Hold |
77,764
| – | – | 1.94% | 17 |
|
|
2019
Q4 | $6.57M | Buy |
+77,764
| New | +$6.57M | 1.26% | 20 |
|